Ten years in the works... and finally, has the government's draft National Pharma Pricing Policy (NPPP) been able to strike the right balance between looking after consumer health and industry wealth? Well, it does not seem so.
Speaking to CNBC-TV18, Kewal Handa, managing director of Pfizer said, the draft NPPP has a few positives but the government needs to re-look at it altogether. "The proposed strict price controls are not warranted," he said adding, "Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
